克利夫兰临床研究发现,在心脏手术后死亡的心脏手术后的死亡的胸部放疗前的胸部放射 与(文档。文档元素]){ 名=类名。取代(\/ \ BNO JS \ \/,“JS”); } 如果(文件的URL。substring(7,9)= =“我”

据美国心脏协会克利夫兰临床研究中心的最新研究显示,接受放射治疗的心脏病心脏手术的患者在手术后的时间几乎是接受放射治疗的患者的两倍循环

The team of researchers, led by Milind Desai, MD, a cardiologist in the Sydell and Arnold Miller Family Heart & Vascular Institute at Cleveland Clinic, examined 173 patients who underwent heart surgery an average of 18 years after receiving chest radiation for cancer and compared the mortality rates to 305 similar heart surgery patients who did not undergo prior radiation。 After an average follow-up of 7。6 years, 55 percent of the patients in the radiation group had died, compared to 28 percent in the non-radiation group。 Short-term mortality (including 30-day mortality) were not significantly different。 In the cases where cause of death could be ascertained, the vast majority died as a result of heart or lung disease and not from recurring cancer。

“Even with low-risk scores and procedural success, chest radiation years or even decades prior to heart surgery puts patients at a much higher risk for long-term events,” said Dr。 Desai。 “Further research needs to be done to understand this patient population and to better stratify their risk so that we can identify the most effective ways to treat their complex disease。”

Radiation therapy is often the most effective way to treat cancers that affect the chest, including cancers of the breast and lung, and Hodgkin and non-Hodgkin lymphoma。 But radiation can cause problems for the heart and its surrounding structure that often manifest themselves years, even decades, later。 Long term, chest radiation can cause coronary artery disease, valve disease, cardiomyopathy -- or weakening of the heart muscle -- and problems with the electronic signals that make the heart beat。

“In radiation heart disease patients, we often see a very peculiar presentation of cardiac disease,” Dr。 Desai said。 “These are often younger patients than typically present with advanced heart disease, and they often have aggressive coronary artery blockages, valve narrowing or leakage -- in many cases involving multiple valves -- and thickening of the sac around the heart。”

The researchers say that it’s important for physicians to recognize when the heart disease is caused by radiation and then decide on the best strategy to treat these patients。

“Not all of these patients are at the same level of risk – there is a spectrum of risk,” Dr。 Desai said。 “We need to develop ways to identify the risks and better determine which patients would benefit from surgery versus other treatments, like percutaneous interventions, for example。”

Dr。 Desai said it’s important for cancer patients who receive chest radiation to know the risks to their hearts and be aware that they could encounter heart disease down the road。

“If you have had prior chest radiation and you are now experiencing heart problems, the two could be linked,” he said。 “It’s vital that you discuss it with your doctor and find a treatment center experienced in treating patients with radiation heart disease – one that has doctors who understand the disease and have the expertise to diagnose and effectively treat it。”

Cleveland Clinic News Service is available to provide broadcast-quality interviews and B-roll upon request。

(注:转载时请注明复诊网)


(注:转载时请注明复诊网)

男性,65岁,弥漫大B非生发中心淋巴瘤病例分析

病史 病人,65岁,2005年患难肠结核治愈 。 2013年11月起纳差,伴上腹痛,2013年12月31日柳州市人民医院 查胃镜,活检病理 :怀疑淋巴瘤2014年1月8日 柳州市工人医院 行胃全切术,术后病理:胃[原文链接]

男性,34岁,滤泡性淋巴瘤病例分析

病史 2010年11月开始咳嗽,无痰,类似于过敏性咳嗽,闻到烟味、做菜油烟味等等就咳嗽,每天下午和傍晚比上午严重。磕了3个月左右,记得是靠可待因溶液和泼尼松吃好的。 2014年3月[原文链接]

哈佛大学医学院教学附属麻省总医院(美国) Mass

麻省总医院建立于1811年,是美国哈佛大学医学院最早、也是规模最大的教学附属医院,全美历史最悠久的三所医院之一。2012年全美医院排名第一(US News World Report)。1846年,进行了人[原文链接]

克利夫兰诊所(美国) Cleveland Clinic

克利夫兰诊所位于美国俄亥俄州的克利夫兰市,是一所集临床治疗、病人护理、研究和教育为一体的非盈利性多专科学术医疗中心。 克利夫兰诊所创办于1921年2月28日。历经灾难和萧条[原文链接]

皇家马斯登癌症中心(英国)The Royal Marsden Hosp

皇家马斯登癌症中心连同ICR是英国国家卫生研究所指定的英国唯一的癌症生物医学研究中心,它于2006年和2011年两次荣获此项殊荣。该医院的开创性研究工作在5年内总共获得了6200万英镑[原文链接]

海德堡大学附属医院(德国)The Heidelberg Univers

医院的宗旨是用卓越的科研手段为病人的健康服务。 德国海德堡大学附属医院不断致力于发展新的诊断和治疗手段,使其处于医学研究的前沿,让所有的患者受益。 德国海德堡大学全[原文链接]

移动医疗,未来5年大预测!

2014年,阿里收购中信二十一世纪,大张旗鼓地直接将医药电商带进百花齐放,百家争鸣的竞争时代。随着全民健康意识、信息技术以及网络覆盖率的提高,传统的有病去医院模式得到了[原文链接]

从实验室到公司,哈佛抗生素成果转化引关注

最近,一家新成立不久的抗生素医药公司Macrolide Pharmaceuticals宣布公司已经完成了总额达2200万美元的首轮融资。可千万不要小看这家名不见经传的小公司,它是由哈佛大学著名的化学家[原文链接]